Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6052-73-9

Post Buying Request

6052-73-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6052-73-9 Usage

Uses

A new pyridone alkaloid as an intermediate in the synthesis of Piperlongumine (P482850).

Check Digit Verification of cas no

The CAS Registry Mumber 6052-73-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,5 and 2 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6052-73:
(6*6)+(5*0)+(4*5)+(3*2)+(2*7)+(1*3)=79
79 % 10 = 9
So 6052-73-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO/c7-5-3-1-2-4-6-5/h1,3H,2,4H2,(H,6,7)

6052-73-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-dihydro-1H-pyridin-6-one

1.2 Other means of identification

Product number -
Other names 5,6-DIHYDRO-1H-PYRIDIN-2-ONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6052-73-9 SDS

6052-73-9Synthetic route

6-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester
128372-89-4

6-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 0℃; for 1h; Inert atmosphere;98%
With trifluoroacetic acid In dichloromethane at 0 - 20℃; for 2h;72%
With trifluoroacetic acid In dichloromethane at 20℃; Inert atmosphere;
3-(phenylselanyl)-1-(trimethylsilyl)piperidin-2-one

3-(phenylselanyl)-1-(trimethylsilyl)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With dihydrogen peroxide In tetrahydrofuran at 0 - 20℃; for 2h;97.7%
In tetrahydrofuran at 0 - 20℃; for 2h;0.55 g
(E)-N-(but-3-en-1-yl)but-2-enamide

(E)-N-(but-3-en-1-yl)but-2-enamide

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In dichloromethane for 2h; Reflux;94%
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In dichloromethane at 40℃; for 2h;56%
3-(phenylthio)piperidin-2-one
104261-03-2

3-(phenylthio)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Stage #1: 3-(phenylthio)piperidin-2-one With sodium hydrogencarbonate In dichloromethane for 0.166667h;
Stage #2: With 3-chloro-benzenecarboperoxoic acid for 1h; Further stages.;
90%
Stage #1: 3-(phenylthio)piperidin-2-one With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0 - 20℃; for 2h;
Stage #2: In toluene for 1h; Reflux;
80%
Multi-step reaction with 2 steps
1: m-CPBA, aq.NaHCO3 / CH2Cl2 / 1 h / 0 °C
2: 1.17 g / benzene / 1 h / Heating
View Scheme
N-(but-3-en-1-yl)prop-2-enamide
1415686-28-0

N-(but-3-en-1-yl)prop-2-enamide

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In toluene at 85 - 90℃; for 7h;75%
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In dichloromethane for 6h; Grubbs Olefin Metathesis; Reflux;70%
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In dichloromethane for 6h; Reflux;70%
2-oxopiperidin-3-yl dimethyldithiocarbamate

2-oxopiperidin-3-yl dimethyldithiocarbamate

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
at 260℃; under 1 Torr;68%
1-(perfluorobenzoyl)-5,6-dihydropyridin-2(1H)-one

1-(perfluorobenzoyl)-5,6-dihydropyridin-2(1H)-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With lithium hydroxide monohydrate In tetrahydrofuran at 50℃; for 4h;68%
(E)-2,4-pentadienoic acid
21651-12-7

(E)-2,4-pentadienoic acid

A

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

B

1,6-dihydropyridin-2(3H)-one
61892-77-1

1,6-dihydropyridin-2(3H)-one

Conditions
ConditionsYield
With ammonia Yield given. Yields of byproduct given;
3-Benzenesulfonyl-piperidin-2-one

3-Benzenesulfonyl-piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
In benzene for 1h; Heating;1.17 g
3-(Phenylselenenyl)-2-piperidinone

3-(Phenylselenenyl)-2-piperidinone

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With dihydrogen peroxide In tetrahydrofuran 1.) 0 deg C, 30 min, 2.) 25 deg C, 1.5 h; Yield given;
1-(trimethylsilyl)piperidin-2-one
3553-93-3

1-(trimethylsilyl)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: LDA / tetrahydrofuran; hexane / 1.) -50 deg C, 45 min, 2.) -78 deg C, 7 h
2: 50percent H2O2 / tetrahydrofuran / 1.) 0 deg C, 30 min, 2.) 25 deg C, 1.5 h
View Scheme
Multi-step reaction with 2 steps
1.1: n-butyllithium / tetrahydrofuran / 0.75 h / -50 °C / Inert atmosphere
1.2: 7 h / -78 °C / Inert atmosphere
2.1: dihydrogen peroxide / tetrahydrofuran / 2 h / 0 - 20 °C
View Scheme
1-(methoxymethyl)-3-(phenylthio)piperidin-2-one
1026076-90-3

1-(methoxymethyl)-3-(phenylthio)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 78 percent / conc.HCl / ethanol / 6 h / Heating
2: m-CPBA, aq.NaHCO3 / CH2Cl2 / 1 h / 0 °C
3: 1.17 g / benzene / 1 h / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: hydrogenchloride / ethanol; water / 6 h / Reflux
2.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 2 h / 0 - 20 °C
2.2: 1 h / Reflux
View Scheme
C2HF3O2*C11H8F5NO2

C2HF3O2*C11H8F5NO2

A

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

B

(3E,9E,15E)-1,7,13-Triaza-cyclooctadeca-3,9,15-triene-2,8,14-trione

(3E,9E,15E)-1,7,13-Triaza-cyclooctadeca-3,9,15-triene-2,8,14-trione

Conditions
ConditionsYield
With 4-methyl-morpholine In 1,4-dioxane at 80℃; for 18h;A 6 mg
B 36 mg
C8H13NO

C8H13NO

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride Grubbs Olefin Metathesis;
2-oxopiperidine-1-carboxylic acid tert-butyl ester
85908-96-9

2-oxopiperidine-1-carboxylic acid tert-butyl ester

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: n-butyllithium; diisopropylamine / tetrahydrofuran / 0.5 h / -78 °C / Inert atmosphere
1.2: 1.5 h / Inert atmosphere
2.1: 3-chloro-benzenecarboperoxoic acid; sodium hydrogencarbonate / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
2.2: 3 h / 80 °C / Inert atmosphere
3.1: hydrogenchloride / methanol; water / 1 h / 0 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1.1: lithium diisopropyl amide / tetrahydrofuran / 0.5 h / -78 °C / Inert atmosphere
1.2: 1.5 h / -78 °C / Inert atmosphere
2.1: 3-chloro-benzenecarboperoxoic acid; sodium hydrogencarbonate / dichloromethane / 2 h / 0 °C
3.1: toluene / 3 h / 80 °C
4.1: trifluoroacetic acid / dichloromethane / 2 h / 0 - 20 °C
View Scheme
N-(tert-butyloxycarbonyl)-3-(phenylthio)piperidine-2-one
358732-56-6

N-(tert-butyloxycarbonyl)-3-(phenylthio)piperidine-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 3-chloro-benzenecarboperoxoic acid; sodium hydrogencarbonate / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
1.2: 3 h / 80 °C / Inert atmosphere
2.1: hydrogenchloride / methanol; water / 1 h / 0 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: 3-chloro-benzenecarboperoxoic acid; sodium hydrogencarbonate / dichloromethane / 2 h / 0 °C
2: toluene / 3 h / 80 °C
3: trifluoroacetic acid / dichloromethane / 2 h / 0 - 20 °C
View Scheme
piperidin-2-one
675-20-7

piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: n-butyllithium / tetrahydrofuran / 0.5 h / -78 °C / Inert atmosphere
1.2: 16 h / 20 °C / Inert atmosphere
2.1: n-butyllithium; diisopropylamine / tetrahydrofuran / 0.5 h / -78 °C / Inert atmosphere
2.2: 1.5 h / Inert atmosphere
3.1: 3-chloro-benzenecarboperoxoic acid; sodium hydrogencarbonate / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
3.2: 3 h / 80 °C / Inert atmosphere
4.1: hydrogenchloride / methanol; water / 1 h / 0 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 13 h / 0 - 20 °C
2: 2,5-di-tert-butyl-p-benzoquinone; palladium(II) trifluoroacetate; racemic methyl phenyl sulfoxide; zinc(II) trifluoroacetate; di-n-butylboryl trifluoromethanesulfonate; N-ethyl-N,N-diisopropylamine / dichloromethane; 1,4-dioxane / 24 h / 20 °C / Inert atmosphere; Sealed tube
3: lithium hydroxide monohydrate / tetrahydrofuran / 4 h / 50 °C
View Scheme
Multi-step reaction with 3 steps
1.1: triethylamine / toluene / 4 h / Inert atmosphere
2.1: tetrahydrofuran / 0.75 h / -50 °C / Alkaline conditions; Enzymatic reaction
2.2: 7 h
3.1: tetrahydrofuran / 2 h / 0 - 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: triethylamine / toluene / 4 h / 50 °C / Inert atmosphere
2.1: n-butyllithium / tetrahydrofuran / 0.75 h / -50 °C / Inert atmosphere
2.2: 7 h / -78 °C / Inert atmosphere
3.1: dihydrogen peroxide / tetrahydrofuran / 2 h / 0 - 20 °C
View Scheme
Multi-step reaction with 4 steps
1.1: n-butyllithium / dichloromethane; tetrahydrofuran / 0.5 h / 0 °C
1.2: 3 h
2.1: lithium diisopropyl amide / tetrahydrofuran / 0.75 h / -78 °C / Inert atmosphere
2.2: -78 - 20 °C
3.1: hydrogenchloride / ethanol; water / 6 h / Reflux
4.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 2 h / 0 - 20 °C
4.2: 1 h / Reflux
View Scheme
1-(perfluorobenzoyl)piperidin-2-one

1-(perfluorobenzoyl)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2,5-di-tert-butyl-p-benzoquinone; palladium(II) trifluoroacetate; racemic methyl phenyl sulfoxide; zinc(II) trifluoroacetate; di-n-butylboryl trifluoromethanesulfonate; N-ethyl-N,N-diisopropylamine / dichloromethane; 1,4-dioxane / 24 h / 20 °C / Inert atmosphere; Sealed tube
2: lithium hydroxide monohydrate / tetrahydrofuran / 4 h / 50 °C
View Scheme
1-(methoxymethyl)piperidin-2-one
50902-27-7

1-(methoxymethyl)piperidin-2-one

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: lithium diisopropyl amide / tetrahydrofuran / 0.75 h / -78 °C / Inert atmosphere
1.2: -78 - 20 °C
2.1: hydrogenchloride / ethanol; water / 6 h / Reflux
3.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 2 h / 0 - 20 °C
3.2: 1 h / Reflux
View Scheme
3-benzenesulfinyl-2-oxo-piperidine-1-carboxylic acid tert-butyl ester

3-benzenesulfinyl-2-oxo-piperidine-1-carboxylic acid tert-butyl ester

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene / 3 h / 80 °C
2: trifluoroacetic acid / dichloromethane / 2 h / 0 - 20 °C
View Scheme
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

cis-3,4-dihydroxy-2-piperidinone
139374-43-9

cis-3,4-dihydroxy-2-piperidinone

Conditions
ConditionsYield
osmium(VIII) oxide; 4-methylmorpholine N-oxide In tert-butyl alcohol Ambient temperature;100%
With osmium(VIII) oxide; 4-methylmorpholine N-oxide In tert-butyl alcohol for 27h; Ambient temperature;64 mg
[2-(hydroxymethyl)phenyl]dimethyl(4-fluorophenyl)silane
853955-70-1

[2-(hydroxymethyl)phenyl]dimethyl(4-fluorophenyl)silane

5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

(R)-4-(4-fluorophenyl)-2-piperidinone

(R)-4-(4-fluorophenyl)-2-piperidinone

Conditions
ConditionsYield
With potassium hydroxide; (1R,4R)-2,5-diphenylbicyclo[2.2.2]octa-2,5-diene; bis(ethylene)rhodium(I) chloride dimer In tetrahydrofuran at 50℃; for 12h;92%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

tris(4-chlorophenyl)boroxine
7519-91-7

tris(4-chlorophenyl)boroxine

(R)-4-(4-chlorophenyl)-2-piperidinone

(R)-4-(4-chlorophenyl)-2-piperidinone

Conditions
ConditionsYield
With (R)-2,2'-bis(diarylphosphino)-1,1'-binaphthyl; water; bis(ethylene)rhodium acetylacetonate In 1,4-dioxane at 60℃; for 12h;88%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

tris(4-fluorophenyl)boroxine
448-59-9

tris(4-fluorophenyl)boroxine

(R)-4-(4-fluorophenyl)-2-piperidinone

(R)-4-(4-fluorophenyl)-2-piperidinone

Conditions
ConditionsYield
With (R)-2,2'-bis(diphenylphosphino)-octahydro-1,1'-binaphthyl; water; bis(ethylene)rhodium acetylacetonate In 1,4-dioxane at 40℃; for 12h;84%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C13H11ClN2O

C13H11ClN2O

(E)-1-(3-(4-((1H-imidazol-1-yl)methyl)phenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

(E)-1-(3-(4-((1H-imidazol-1-yl)methyl)phenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With sodium hydride In tetrahydrofuran; mineral oil at -5 - 0℃; for 2h;
Stage #2: C13H11ClN2O In tetrahydrofuran; mineral oil for 21h;
82%
With triethylamine In tetrahydrofuran at 0℃; for 3h;
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

formic acid ethyl ester
109-94-4

formic acid ethyl ester

N-formyl-5,6-dihydropyridine-2(1H)-one

N-formyl-5,6-dihydropyridine-2(1H)-one

Conditions
ConditionsYield
With titanium tetrachloride; triethylamine In dichloromethane at 0℃; for 1h;76%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C23H24Cl2O7

C23H24Cl2O7

piperarborenine B

piperarborenine B

Conditions
ConditionsYield
In toluene at 20 - 80℃; for 12h; Inert atmosphere; Molecular sieve;75%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C16H9ClO5

C16H9ClO5

C21H15NO6

C21H15NO6

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 10h;75%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

1-chloro-5,6-dihydropyridin-2(1H)-one
1215765-27-7

1-chloro-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
With N-chloro-succinimide; potassium tert-butylate In tetrahydrofuran at 20℃; for 0.666667h; Inert atmosphere;74%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

p-phenylenediacrylic diacid dichloride
35288-49-4

p-phenylenediacrylic diacid dichloride

C22H20N2O4

C22H20N2O4

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.25h;
Stage #2: p-phenylenediacrylic diacid dichloride In tetrahydrofuran; hexane at -78℃; for 3h;
72%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

2-Nitrobenzenesulfonyl chloride
1694-92-4

2-Nitrobenzenesulfonyl chloride

1-nosyl-5,6-dihydropyridin-2(1H)-one
1266568-91-5

1-nosyl-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h; Inert atmosphere;
Stage #2: 2-Nitrobenzenesulfonyl chloride In tetrahydrofuran; hexane at -78℃; for 1.5h; Inert atmosphere;
71%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

2,2-diethoxy-ethanamine
645-36-3

2,2-diethoxy-ethanamine

5,6-Dihydroimidazo<1,2-a>pyridine

5,6-Dihydroimidazo<1,2-a>pyridine

Conditions
ConditionsYield
titanium tetrachloride In 1,3,5-trimethyl-benzene for 74h; Heating;68.9%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C19H31NO5

C19H31NO5

tert-butyl (E)-4-(2-methyl-3-oxo-3-(6-oxo-3,6-dihydropyridin-1(2H)-yl)prop-1-en-1-yl)piperidine-1-carboxylate

tert-butyl (E)-4-(2-methyl-3-oxo-3-(6-oxo-3,6-dihydropyridin-1(2H)-yl)prop-1-en-1-yl)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: C19H31NO5 In tetrahydrofuran at -78 - 20℃; for 1h;
67.8%
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: C19H31NO5 In tetrahydrofuran at 20℃; for 1h;
67.8%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

chloroacetyl chloride
79-04-9

chloroacetyl chloride

1-(2-chloroacetyl)-5,6-dihydropyridin-2(1H)-one

1-(2-chloroacetyl)-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With sodium hydride In tetrahydrofuran at 0℃; for 1h; Inert atmosphere;
Stage #2: chloroacetyl chloride In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
65%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C13H14Cl3NO

C13H14Cl3NO

C18H20Cl2N2O2

C18H20Cl2N2O2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 10h;65%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

cinnamyl chloride
2687-12-9

cinnamyl chloride

1-cinnamoyl-5,6-dihydropyridin-2(1H)-one
1057962-70-5

1-cinnamoyl-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With sodium hydride In tetrahydrofuran at 0℃; for 0.25h; Inert atmosphere;
Stage #2: cinnamyl chloride In tetrahydrofuran at 20℃; for 0.5h; Inert atmosphere;
64%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

mesitylenecarbonitrile oxide
2904-57-6

mesitylenecarbonitrile oxide

3-(2,4,6-trimethyl-phenyl)-5,6,7,7a-tetrahydro-3aH-isoxazolo[4,5-c]pyridin-4-one

3-(2,4,6-trimethyl-phenyl)-5,6,7,7a-tetrahydro-3aH-isoxazolo[4,5-c]pyridin-4-one

Conditions
ConditionsYield
In benzene at 20℃; for 504000h; Cycloaddition;62%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C10H11ClN2O

C10H11ClN2O

(E)-1-{3-[(3,5,6-trimethylpyrazin-2-yl)]prop-2-enoyl}-5,6-dihydropyridin-2(1H)-one

(E)-1-{3-[(3,5,6-trimethylpyrazin-2-yl)]prop-2-enoyl}-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: C10H11ClN2O With pivaloyl chloride; triethylamine In tetrahydrofuran at -20℃; for 0.75h;
Stage #2: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -70℃; for 1.75h;
53%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

(2E)-3-(3,5,6-trimethylpyrazin-2-yl)prop-2-enoic acid

(2E)-3-(3,5,6-trimethylpyrazin-2-yl)prop-2-enoic acid

(E)-1-{3-[(3,5,6-trimethylpyrazin-2-yl)]prop-2-enoyl}-5,6-dihydropyridin-2(1H)-one

(E)-1-{3-[(3,5,6-trimethylpyrazin-2-yl)]prop-2-enoyl}-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: (2E)-3-(3,5,6-trimethylpyrazin-2-yl)prop-2-enoic acid With pivaloyl chloride; triethylamine In tetrahydrofuran; dichloromethane at -20℃;
Stage #2: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran for 1h;
53%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

(E)-(E)-3-(5-methoxypyrimidin-2-yl)acrylic pivalic anhydride

(E)-(E)-3-(5-methoxypyrimidin-2-yl)acrylic pivalic anhydride

(E)-1-(3-(5-methoxypyrimidin-2-yl)acryloyl)-5,6-dihydropyridin-2(1H)-one

(E)-1-(3-(5-methoxypyrimidin-2-yl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h;
Stage #2: (E)-(E)-3-(5-methoxypyrimidin-2-yl)acrylic pivalic anhydride In tetrahydrofuran; hexane at -78℃; for 1h;
52.23%
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h;
Stage #2: (E)-(E)-3-(5-methoxypyrimidin-2-yl)acrylic pivalic anhydride In tetrahydrofuran; hexane at -78℃; for 1h;
52.23%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

benzohydroximoyl chloride
698-16-8

benzohydroximoyl chloride

3-phenyl-5,6,7,7a-tetrahydro-3aH-isoxazolo[4,5-c]pyridin-4-one

3-phenyl-5,6,7,7a-tetrahydro-3aH-isoxazolo[4,5-c]pyridin-4-one

Conditions
ConditionsYield
With triethylamine In benzene at 20℃; for 48h; Cycloaddition; dehydrochlorination;51%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

C19H31NO5

C19H31NO5

(Z)-tert-butyl 4-(2-methyl-3-oxo-3-(2-oxo-5,6-dihydropyridin-1(2H)-yl)prop-1-enyl)piperidine-1-carboxylate

(Z)-tert-butyl 4-(2-methyl-3-oxo-3-(2-oxo-5,6-dihydropyridin-1(2H)-yl)prop-1-enyl)piperidine-1-carboxylate

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: C19H31NO5 In tetrahydrofuran at -78 - 20℃; for 1h;
49.6%
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: C19H31NO5 In tetrahydrofuran at 20℃; for 1h;
49.6%
5,6-dihydro-2(1H)-pyridinone
6052-73-9

5,6-dihydro-2(1H)-pyridinone

(E)-(E)-3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acrylic pivalic anhydride

(E)-(E)-3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acrylic pivalic anhydride

(E)-1-(3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acryloyl)-5,6-dihydropyridin-2(1H)-one

(E)-1-(3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Conditions
ConditionsYield
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h;
Stage #2: (E)-(E)-3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acrylic pivalic anhydride In tetrahydrofuran; hexane at -78℃; for 1.5h;
48.92%
Stage #1: 5,6-dihydro-2(1H)-pyridinone With n-butyllithium In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: (E)-(E)-3-(3,5-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)acrylic pivalic anhydride In tetrahydrofuran at -78℃; for 1.5h;
48.92%

6052-73-9Relevant articles and documents

Sundberg,R.J. et al.

, p. 2938 - 2941 (1967)

Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor

Fan, Qing-Zhu,Zhou, Ji,Zhu, Yi-Bao,He, Lian-Jun,Miao, Dong-Dong,Zhang, Sheng-Peng,Liu, Xiao-Ping,Zhang, Chao

, (2020/11/02)

Targeting the Trp-Kyn pathway is an attractive approach for cancer immunotherapy. Thioredoxin reductase (TrxR) enzymes are reactive oxygen species (ROS) modulators that are involved in the tumor cell growth and survival processes. The 4-phenylimidazole scaffold is well-established as useful for indoleamine 2,3-dioxygenase 1 (IDO1) inhibition, while piperlongumine (PL) and its derivatives have been reported to be inhibitors of TrxR. To take advantage of both immunotherapy and TrxR inhibition, we designed a first-generation dual IDO1 and TrxR inhibitor (ZC0101) using the structural combination of 4-phenylimidazole and PL scaffolds. ZC0101 exhibited better dual inhibition against IDO1 and TrxR in vitro and in cell enzyme assays than the uncombined forms of 4-phenylimidazole and PL. It also showed antiproliferative activity in various cancer cell lines, and a selective killing effect between normal and cancer cells. Furthermore, ZC0101 effectively induced apoptosis and ROS accumulation in cancer cells. Knockdown of TrxR1 and IDO1 expression induced cellular enzyme inhibition and ROS accumulation effects during ZC0101 treatment, but only reduced TrxR1 expression was able to improve ZC0101′s antiproliferation effect. This proof-of-concept study provides a novel strategy for cancer treatment. ZC0101 represents a promising lead compound for the development of novel antitumor agents that can also be used as a valuable probe to clarify the relationships and mechanisms of cancer immunotherapy and ROS modulators.

Activity-based protein profiling reveals GSTO1 as the covalent target of piperlongumine and a promising target for combination therapy for cancer

Li, Li,Zhao, Yue,Cao, Ran,Li, Lin,Cai, Gaihong,Li, Jiaojiao,Qi, Xiangbing,Chen, She,Zhang, Zhiyuan

, p. 4407 - 4410 (2019/04/26)

Through systematic target identification for piperlongumine, a cancer-selective killing molecule, we identified GSTO1 as its major covalent target for cancer cell death induction. We also reveal that GSTO1 inhibition is a promising combination strategy with other anti-cancer agents by drug combination screening in which piperlongumine exhibits broad-spectrum synergistic effects with a large proportion of the tested anti-cancer agents, especially with PI3K/Akt/mTOR pathway inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6052-73-9